The HER2CLIMB-05 trial is a randomized, double blind, placebo-controlled, pivotal Phase 3 study evaluating the efficacy and safety of TUKYSA compared to placebo, both in combination with trastuzumab ...

NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 fourth-quarter 2026 dividend on the company’s common stock, payable December 7, 2026, ...

LITFULO significantly improved facial and total body repigmentation at Week 52 compared to placebo, with continuous improvement starting at Week 24, supporting planned regulatory filings for a ...

Pfizer Inc. (NYSE: PFE) will present data from 45 company-sponsored, investigator-sponsored, and collaborative research abstracts at the European Society for Medical Oncology (ESMO) Congress, taking ...

(NYSE: PFE) today presented detailed results from an ongoing Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate-t ...

For Washington residents, please visit our Washington Health Data Privacy Policy to review our privacy practices related to your health data.

The 230-acre site in Sanford, North Carolina, just south of the famed Research Triangle, is home to one of the largest U.S. biotechnology hubs. The site has flexible, multi-product manufacturing ...

Understand the types of multiple myeloma, signs and symptoms of the disease as well as common symptoms, risk factors, and current treatment options. Multiple myeloma is a type of cancer that forms in ...

Pfizer believes that privacy is a fundamental right. Personal data is at the core of scientific and medical innovation, and your personal health data can play a critical role in helping you and your ...

A holdover from our prehistoric days, goosebumps are the end result of an adrenaline rush meant to ward off a big chill — or predators. It’s a common occurrence. A sudden freezing gust of wind or ...